New Frontiers: Harnessing Advanced Data Science to Understand the Impact of Medical Congresses on HCPs
At a Glance
- Enhanced Intelligence: DrugVoice’s AI-driven analysis offers a comprehensive view of congress discussions.
- Informed Decision-Making: Empower Med Comms agencies to provide end clients with actionable intelligence.
- Robust Quality and Compliance Standards: High standards in quality and ethics.
Customer Objective
Medical Comms agencies can harness the Advanced Data Science and AI capabilities of Talking Medicines DrugVoice to unlock intelligence regarding Medical Congress events. The primary purpose is to deliver actionable insights to end clients, including:
- Share of Voice Analysis: Measure and compare mentions of medicines by therapeutic use across competitive set.
- Drivers of Conversational Themes: Identify key topics and emerging trends from discussions.
- Topic and Sentiment Analysis: Understand topics and scientific discussions pre/during/post congress.
- Longitudinal HCP Sentiment Tracking: Monitor HCP sentiment over time through curated data.
Brief
Ingestion and curation of diverse 1st, 2nd and/or 3rd party data sources:
- Raw data from the Medical Congress itself.
- Unstructured Open and Closed Community Conversational data.
This data is curated with Advanced Data Science and AI technologies, enabling a deeper understanding of the impact of Medical Congresses on HCPs – through surfacing Persona Development, Audience Intelligence and Message Alignment. KPIs can be established and tracked over time with measurement.
Solution
Customer-Specific PPT Deck:
- Tailored to answer specific end client questions.
- Clear visual representation of key findings, insights, and trends.
Online access to DrugVoice Platform:
- Enables qualitative exploration of the curated dataset.
- Provides reliable answers adhering to the highest standards of quality and compliance.
By integrating DrugVoice, Med Comms agencies can elevate their congress analysis offerings, allowing them to understand the impact of Medical Congresses on HCPs – which adds significant value to end clients. By working across an annual program with DrugVoice, the Med Comms agencies can maximize efficiency and effectiveness of their congress insights.
Contact Britt Gibson, Manager Global Customer Engagement, at britt@talkingmedicines.com.
Read More
